This compound is a pharmaceutical intermediate featuring a thiazole ring and a cyano-substituted phenyl ether structure. It is primarily used as a building block in the synthesis of active pharmaceutical ingredients.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 160844-75-7
Febuxostat
active pharmaceutical ingredient
2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)aniline
pharmaceutical intermediate
1-[7-Amino-5-(2-bromopropyl)-2,3-dihydro-1H-indol-1-yl]ethanone
Pharmaceutical intermediate for synthesis
2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl Methanesulfonate
pharmaceutical intermediate
3-Acetyl-2-(aminosulfonyl)-5-chlorothiophene
Pharmaceutical intermediate for sulfonamide synthesis
Ethyl 2-[3-formyl-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylate
pharmaceutical intermediate
Ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methyl-5-thiazolecarboxylate
pharmaceutical intermediate
Ethyl 2-(4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylate
Pharmaceutical intermediate for thiazole derivatives
ethyl 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylate
OGAZOYHQFBSRMC-UHFFFAOYSA-N
CCOC(=O)C1=C(N=C(S1)C2=CC(=C(C=C2)OCC(C)C)C#N)C